title: Comparative clinical and pharmacokinetic aspects of cefotetan versus cefoxitin plus metronidazole in vaginal hysterectomy.
authors.affiliation: Univ.-Frauenklinik, Heidelberg, FRG.
authors.forename: K
authors.initials: K
authors.lastname: Engel
authors.forename: W
authors.initials: W
authors.lastname: Schmidt
authors.forename: H G
authors.initials: HG
authors.lastname: Sonntag
authors.forename: F
authors.initials: F
authors.lastname: Kees
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D001424:Bacterial Infections / Q000517:prevention & control; D015313:Cefotetan / Q000627:therapeutic use*; D002440:Cefoxitin / Q000627:therapeutic use*; D002584:Cervix Uteri / Q000382:microbiology; D005260:Female; D006801:Humans; D007045:Hysterectomy, Vaginal / Q000009:adverse effects*; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D013530:Surgical Wound Infection / Q000517:prevention & control*; D014621:Vagina / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents; D015313:Cefotetan; D002440:Cefoxitin